Health Catalyst, Inc. (HCAT) is a publicly traded company in the Unknown sector. Across all available filings, 34 corporate insiders have executed 889 transactions totaling $103.9M, demonstrating a bearish sentiment with -$92.0M in net insider flow. The most recent transaction on Feb 17, 2026 involved a transaction of 7,562 shares valued at $0.
No significant insider buying has been recorded for HCAT in the recent period.
No significant insider selling has been recorded for HCAT in the recent period.
Based on recent SEC filings, insider sentiment for HCAT is bearish with an Insider Alignment Score of 6/100 and a net flow of -$92.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Health Catalyst, Inc. (HCAT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 34 insiders are actively trading HCAT stock, having executed 889 transactions in the past 90 days. The most active insider is Daniel D. Burton (Executive), who has made 111 transactions totaling $72.7M.
Get notified when executives and directors at HCAT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Gallagher Duncan | Executive | Award | 7,562 | $N/A | $0 | |
| Dec 5, 2025 | Landry Benjamin | Executive | Sale | 27,425 | $2.64 | $72.4K | |
| Dec 4, 2025 | Larson-green Julie | Executive | Sale | 47,997 | $2.67 | $128.2K | |
| Dec 1, 2025 | D. Burton Daniel | Executive | Payment | 55,715 | $2.90 | $161.6K | |
| Dec 1, 2025 | Alger Jason | Executive | Payment | 20,619 | $2.90 | $59.8K | |
| Dec 1, 2025 | Lee Freeman Kevin | Executive | Payment | 16,401 | $2.90 | $47.6K | |
| Dec 1, 2025 | Llewelyn Linda | Executive | Payment | 9,762 | $2.90 | $28.3K | |
| Dec 1, 2025 | Landry Benjamin | Executive | Payment | 14,387 | $2.90 | $41.7K | |
| Dec 1, 2025 | Gallagher Duncan | Executive | Award | 6,209 | $N/A | $0 | |
| Dec 1, 2025 | Larson-green Julie | Executive | Award | 5,731 | $N/A | $0 | |
| Sep 24, 2025 | Albert Benjamin | Executive | Award | 467,000 | $N/A | $0 | |
| Sep 5, 2025 | Landry Benjamin | Executive | Sale | 6,175 | $3.35 | $20.7K | |
| Sep 2, 2025 | Landry Benjamin | Executive | Payment | 3,138 | $3.36 | $10.5K | |
| Sep 2, 2025 | Llewelyn Linda | Executive | Payment | 2,854 | $3.36 | $9.6K | |
| Sep 2, 2025 | D. Burton Daniel | Executive | Payment | 8,335 | $3.36 | $28.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 355 | $98.0M | 70.7% |
Exercise(M) | 208 | $27.5M | 19.8% |
Payment(F) | 142 | $7.3M | 5.2% |
Purchase(P) | 7 | $5.9M | 4.3% |
Award(A) | 113 | $0 | 0.0% |
Gift(G) | 3 | $0 | 0.0% |
Other(J) | 44 | $0 | 0.0% |
Conversion(C) | 17 | $0 | 0.0% |
Insider selling pressure at Health Catalyst, Inc. has increased, with 34 insiders executing 889 transactions across all time. Total sales of $98.0M significantly outpace purchases of $5.9M, resulting in a net outflow of $92.0M. This selling activity appears largely discretionary, which may warrant closer attention from investors.